For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Skye Bioscience Inc (NASDAQ: SKYE) closed at $4.35 in the last session, down -0.91% from day before closing price of $4.39. In other words, the price has decreased by -$0.91 from its previous closing price. On the day, 0.84 million shares were traded. SKYE stock price reached its highest trading level at $4.44 during the session, while it also had its lowest trading level at $3.97.
Ratios:
We take a closer look at SKYE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.85 and its Current Ratio is at 11.85. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On September 30, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $20.
On September 10, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $15.JMP Securities initiated its Mkt Outperform rating on September 10, 2024, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when Diep Tuan Tu sold 19,489 shares for $4.99 per share. The transaction valued at 97,250 led to the insider holds 82,259 shares of the business.
Diep Tuan Tu sold 85 shares of SKYE for $472 on Nov 15 ’24. The Chief Development Officer now owns 101,748 shares after completing the transaction at $5.55 per share. On Nov 18 ’24, another insider, ARSENAULT KAITLYN, who serves as the Chief Financial Officer of the company, sold 43,206 shares for $4.99 each. As a result, the insider received 215,598 and left with 166,342 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SKYE now has a Market Capitalization of 134782144 and an Enterprise Value of 70702776.
Stock Price History:
The Beta on a monthly basis for SKYE is 2.23, which has changed by -0.28571427 over the last 52 weeks, in comparison to a change of 0.10500872 over the same period for the S&P500. Over the past 52 weeks, SKYE has reached a high of $7.47, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is 74.38%, while the 200-Day Moving Average is calculated to be 40.85%.
Shares Statistics:
According to the various share statistics, SKYE traded on average about 1.32M shares per day over the past 3-months and 2655550 shares per day over the past 10 days. A total of 30.97M shares are outstanding, with a floating share count of 17.86M. Insiders hold about 42.35% of the company’s shares, while institutions hold 41.27% stake in the company. Shares short for SKYE as of 1749772800 were 2816636 with a Short Ratio of 2.13, compared to 1747267200 on 3212389. Therefore, it implies a Short% of Shares Outstanding of 2816636 and a Short% of Float of 13.66.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
